AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Study

July 23, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search